Clinical Trials Logo

Filter by:
  • Active, not recruiting  
  • Page [1] ·  Next »
NCT ID: NCT05729620 Active, not recruiting - Clinical trials for End Stage Renal Disease

Evaluation of STARgraft-3 for Hemodialysis

Start date: November 29, 2022
Phase: N/A
Study type: Interventional

This study is a single site, prospective, single arm evaluation of the safety and effectiveness of the Healionics STARgraft-3 hemodialysis access graft. STARgraft devices have been demonstrated in preclinical and other studies to have improved resistance to the common failure modes of venous anastomosis stenosis and infection. This study is an extension from prior studies with STARgraft AV (NCT03916731) and STARgraft-2 (NCT04783779) investigational devices. A previous study also included control implants of commercially available standard ePTFE grafts approved for the same use. The study is enrolling patients with End Stage Renal Disease (ESRD) requiring hemodialysis via a prosthetic vascular graft. The study proposes to evaluate the performance of the investigational STARgraft-3 compared to the ePTFE controls in the prior study and to published results, over a period of 6 months, with extended results to 1 year. Estimated enrollment is 15 subjects in this study.

NCT ID: NCT05418816 Active, not recruiting - Clinical trials for Chronic Kidney Diseases

SelfWrap-Assisted Arteriovenous Fistulas

SW-AVF
Start date: June 14, 2021
Phase: N/A
Study type: Interventional

This is a single-center, prospective, single-arm clinical study to evaluate the feasibility, safety, and performance of VenoStent's SelfWrap® Bioabsorbable Perivascular Wrap on arteriovenous fistulas (AVFs). All participants are chronic kidney disease (CKD) patients already receiving hemodialysis treatments that are referred for creation of a new arteriovenous fistula (AVF).

NCT ID: NCT04864652 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea of Adult

Safety and Dosing Study of the CHILLS Cryotherapy for the Treatment of OSA

ARCTIC-1
Start date: November 30, 2020
Phase: N/A
Study type: Interventional

ARCTIC-1 is a safety and dosing study to evaluate procedure tolerability in patients with clinically diagnosed moderate or severe OSA.

NCT ID: NCT04807283 Active, not recruiting - Atrial Fibrillation Clinical Trials

Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System

Start date: March 5, 2021
Phase: N/A
Study type: Interventional

The objective of this study is to demonstrate safety and effectiveness using a percutaneous Delivery System of the Laminar Left Atrial Appendage Closure System to treat patients with NVAF to reduce the risk of thromboembolism from the left atrial appendage (LAA).

NCT ID: NCT04281940 Active, not recruiting - Clinical trials for Mitral Valve Regurgitation

Chordal Repair for Transcatheter Mitral Valve Repair (TMVr)

Start date: March 18, 2022
Phase: N/A
Study type: Interventional

A multi-center evaluation of the Pipeline chordal repair system for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve repair.

NCT ID: NCT04141098 Active, not recruiting - Clinical trials for Degenerative Disc Disease

Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy

LOPAIN1
Start date: October 10, 2019
Phase: N/A
Study type: Interventional

This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device deployed to reduce chronic low back pain.

NCT ID: NCT04036253 Active, not recruiting - Clinical trials for Anemia of Chronic Kidney Disease

Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease

Start date: February 28, 2018
Phase: Phase 3
Study type: Interventional

Phase III, multicenter, randomized, open, controlled clinical trial. A study designed as phase III, in 120 patients with chronic renal failure in the pre-dialysis stage, evaluate efficacy and safety of Hemax PFS® (PFS: prefilled syringes) vs the innovator erythropoietin alfa product (Eprex®).

NCT ID: NCT03997994 Active, not recruiting - Biliary Stricture Clinical Trials

DIGEST I Drug Coated Balloon for Biliary Stricture

DIGEST
Start date: May 12, 2019
Phase: N/A
Study type: Interventional

DIGEST I Pilot study is a feasibility study for evaluating the safety and efficacy of DCBs.

NCT ID: NCT03886324 Active, not recruiting - Clinical trials for Intestinal Stricture

POISE I Pilot Study

POISE
Start date: February 25, 2019
Phase: N/A
Study type: Interventional

POISE I study is a feasibility study for evaluating the safety and efficacy of DCB.

NCT ID: NCT03885310 Active, not recruiting - Clinical trials for Esophageal Stricture

INGEST I Pilot Study

INGEST
Start date: February 24, 2019
Phase: N/A
Study type: Interventional

INGEST I Pilot study is a feasibility study for evaluating the safety and efficacy of DCBs.